CATEGORY

Browse all posts in this category.

CIMAR Outreach Day Provides High Schoolers Rare Educational and Networking Opportunities

May 23, 2019

The Tufts Center for Integrated Management of Antimicrobial Resistance hosted 33 students from Boston-area Brockton High School last week for a science outreach event. The students presented posters depicting original experiments and data on antimicrobial resistance to a wide audience of Tufts University and Tufts Medical Center graduate students, postdoctoral fellows, faculty, and clinicians.

Tufts Researchers Find Link Between Dog-Human Antibiotic Resistance

For many people, pets are family; just as close to them as the humans in their life. However, a new study suggests that closeness can create a concerning health issue making prescribed medicines less effective. …

IDSA announces Tufts Medical Center Among Recipients of Antimicrobial Stewardship Centers of Excellence Designation

The Infectious Diseases Society of America (IDSA) announced today the recipients of its Antimicrobial Stewardship Centers of Excellence (CoE) designation. …

CIMAR Featured in Spotlight on Research and Collaboration

Given an increasingly difficult funding climate, finding the research strengths of the university and focusing resources on those areas is a priority for Tufts. After a year-and-a-half consultative process involving researchers from across the university, five thematic priority areas emerged. …

CIMAR Joins the Battle Against AMR with Collaborative and Brainstorming Workshop

The Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR) hosted its first event last month to introduce the Center to the local scientific community and to offer a platform for investigators and clinicians to showcase their research and promote collaborations.

Tufts Summer Programs Provide Research Opportunities for Undergraduates

Tufts prides itself on being a distinguished research university, providing students with opportunities to apply what they have learned in the classroom to the real world. …

Engineering Phages as Novel Antimicrobials Targeting Gram-Negative Pathogens – Massachusetts General Hospital’s Bryan Lenneman, Ph.D.

March 30, 2023

MGH Research Fellow Bryan Lenneman, PhD, is interested in utilizing synthetic biology to develop novel therapeutics against diseases associated with dysbiosis of the human gut microbial community.

CIMAR Joins the Battle Against AMR with Collaborative and Brainstorming Workshop

January 21, 2019

The Tufts Center for Integrated Management of Antimicrobial Resistance (CIMAR) hosted its first event last month to introduce the Center to the local scientific community and to offer a platform for investigators and clinicians to showcase their research and promote collaborations. CIMAR aims to address the rise and spread of antimicrobial resistance (AMR), and we believe our faculty possess the myriad unique skillsets needed to lead this fight. Roughly 700,000 human deaths are attributable to AMR each year globally, and if trends continue, AMR could contribute to a total of 350 million deaths by 2050.

Exploring The Intersection Of Racism, Antimicrobial Resistance, And Vaccine Equity — UC San Diego’s Jacinda C. Abdul-Mutakabbir PharmD, MPH, AAHIVP

February 29, 2024

Dr. Jacinda Abdul-Mutakabbir explores the intersection of antibiotic resistance and health/vaccine equity, with a specific focus on racial differences observed across racially and ethnically minoritized groups.

Levy CIMAR's New Research Hub to Tackle Antimicrobial Resistance

In a significant stride toward combating the global threat of antimicrobial resistance, Tufts University has launched the Laboratory for Combinatorial Drug Regimen Design for Resistant and Emerging Pathogens (LCDRD). Made possible by a $5.15 million grant from the National Institutes of Health, the new facility is housed within the Levy CIMAR and located on the 8th floor of Tufts’ Biomedical Research and Public Health Building on its Health Sciences Campus in Boston. The 2,500-square-foot lab is designed to foster collaboration among scientists, clinicians, and engineers from across Tufts University, Tufts Medicine, and national and international partners. Situated adjacent to Tufts’ BSL-3 lab and key research groups, it supports a uniquely interdisciplinary research environment with state-of-the-art investigative and safety amenities.